Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Hospital contribution to variation in rates of vaginal birth after cesarean.

Triebwasser JE, Kamdar NS, Langen ES, Moniz MH, Basu T, Syrjamaki J, Thomason AC, Smith RD, Morgan DM.

J Perinatol. 2019 Apr 5. doi: 10.1038/s41372-019-0373-2. [Epub ahead of print]

PMID:
30952949
2.

Extended-Duration Use of Direct Oral Anticoagulants to Prevent VTE in Acutely III Medical Patients.

Skelley JW, Thomason AR, Hammond LN.

Sr Care Pharm. 2019 Feb 1;34(2):99-108. doi: 10.4140/TCP.n.2019.99..

PMID:
30821668
3.

Development of NanoLuc-PEST expressing Leishmania mexicana as a new drug discovery tool for axenic- and intramacrophage-based assays.

Berry SL, Hameed H, Thomason A, Maciej-Hulme ML, Saif Abou-Akkada S, Horrocks P, Price HP.

PLoS Negl Trop Dis. 2018 Jul 12;12(7):e0006639. doi: 10.1371/journal.pntd.0006639. eCollection 2018 Jul.

4.

Correction to Discovery of Novel 3-Quinoline Carboxamides as Potent, Selective, and Orally Bioavailable Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase.

Degorce SL, Barlaam B, Cadogan E, Dishington A, Ducray R, Glossop SC, Hassall LA, Lach F, Lau A, McGuire TM, Nowak T, Ouvry G, Pike KG, Thomason AG.

J Med Chem. 2018 Jul 26;61(14):6398. doi: 10.1021/acs.jmedchem.8b00936. Epub 2018 Jul 3. No abstract available.

PMID:
29969258
5.

Orally Bioavailable and Blood-Brain Barrier-Penetrating ATM Inhibitor (AZ32) Radiosensitizes Intracranial Gliomas in Mice.

Karlin J, Allen J, Ahmad SF, Hughes G, Sheridan V, Odedra R, Farrington P, Cadogan EB, Riches LC, Garcia-Trinidad A, Thomason AG, Patel B, Vincent J, Lau A, Pike KG, Hunt TA, Sule A, Valerie NCK, Biddlestone-Thorpe L, Kahn J, Beckta JM, Mukhopadhyay N, Barlaam B, Degorce SL, Kettle J, Colclough N, Wilson J, Smith A, Barrett IP, Zheng L, Zhang T, Wang Y, Chen K, Pass M, Durant ST, Valerie K.

Mol Cancer Ther. 2018 Aug;17(8):1637-1647. doi: 10.1158/1535-7163.MCT-17-0975. Epub 2018 May 16.

PMID:
29769307
6.

Intentional Interprofessional Experiential Education.

Grice GR, Thomason AR, Meny LM, Pinelli NR, Martello JL, Zorek JA.

Am J Pharm Educ. 2018 Apr;82(3):6502. doi: 10.5688/ajpe6502.

7.

Betrixaban (Bevyxxa): A Direct-Acting Oral Anticoagulant Factor Xa Inhibitor.

Skelley JW, Thomason AR, Nolen JC, Candidate P.

P T. 2018 Feb;43(2):85-120.

8.

A candidate tolerance gene identified in a natural population of field voles (Microtus agrestis).

Wanelik KM, Begon M, Birtles RJ, Bradley JE, Friberg IM, Jackson JA, Taylor CH, Thomason AG, Turner AK, Paterson S.

Mol Ecol. 2018 Feb;27(4):1044-1052. doi: 10.1111/mec.14476. Epub 2018 Feb 7.

PMID:
29290094
9.

Half the story: Thermal effects on within-host infectious disease progression in a warming climate.

Stewart A, Hablützel PI, Brown M, Watson HV, Parker-Norman S, Tober AV, Thomason AG, Friberg IM, Cable J, Jackson JA.

Glob Chang Biol. 2018 Jan;24(1):371-386. doi: 10.1111/gcb.13842. Epub 2017 Sep 1.

PMID:
28746785
10.

Endemic Hantavirus in Field Voles, Northern England.

Thomason AG, Begon M, Bradley JE, Paterson S, Jackson JA.

Emerg Infect Dis. 2017 Jun;23(6):1033-1035. doi: 10.3201/eid2306.161607.

11.

Role of Novel Oral Anticoagulants in the Treatment of Antiphospholipid Syndrome.

White CW, Thomason AR, Boyd K.

Hosp Pharm. 2016 Oct;51(9):759-767.

12.

The use of direct oral anticoagulants in inherited thrombophilia.

Skelley JW, White CW, Thomason AR.

J Thromb Thrombolysis. 2017 Jan;43(1):24-30. doi: 10.1007/s11239-016-1428-2. Review.

PMID:
27734187
13.

IFN-β Facilitates Neuroantigen-Dependent Induction of CD25+ FOXP3+ Regulatory T Cells That Suppress Experimental Autoimmune Encephalomyelitis.

Wang D, Ghosh D, Islam SM, Moorman CD, Thomason AE, Wilkinson DS, Mannie MD.

J Immunol. 2016 Oct 15;197(8):2992-3007. Epub 2016 Sep 12.

14.

Discovery of Novel 3-Quinoline Carboxamides as Potent, Selective, and Orally Bioavailable Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase.

Degorce SL, Barlaam B, Cadogan E, Dishington A, Ducray R, Glossop SC, Hassall LA, Lach F, Lau A, McGuire TM, Nowak T, Ouvry G, Pike KG, Thomason AG.

J Med Chem. 2016 Jul 14;59(13):6281-92. doi: 10.1021/acs.jmedchem.6b00519. Epub 2016 Jun 16. Erratum in: J Med Chem. 2018 Jul 26;61(14):6398.

PMID:
27259031
15.

Seasonal immunoregulation in a naturally-occurring vertebrate.

Brown M, Hablützel P, Friberg IM, Thomason AG, Stewart A, Pachebat JA, Jackson JA.

BMC Genomics. 2016 May 18;17:369. doi: 10.1186/s12864-016-2701-7.

16.

New cardiovascular guidelines: Clinical practice evidence for the nurse practitioner.

Lefler LL, Hadley M, Tackett J, Thomason AP.

J Am Assoc Nurse Pract. 2016 May;28(5):241-8. doi: 10.1002/2327-6924.12262. Epub 2015 May 26.

PMID:
26011030
17.

Enhancing discourse in AJPE.

Brazeau GA, Thomason A.

Am J Pharm Educ. 2015 Apr 25;79(3):31. doi: 10.5688/ajpe79331. No abstract available.

18.

Factors Affecting Gynecologic and Sexual Assessment in Older Women: A Lesson for Primary Care Providers.

Thomason A, Capps N, Lefler L, Richard-Davis G.

Healthcare (Basel). 2015 Aug 11;3(3):683-94. doi: 10.3390/healthcare3030683.

19.

Recurrent venous thromboembolism in a patient with heterozygous factor v leiden mutation.

White CW, Thomason AR, Prince V.

Hosp Pharm. 2014 Sep;49(8):748-51. doi: 10.1310/hpj4908-748.

20.

AZD3514: a small molecule that modulates androgen receptor signaling and function in vitro and in vivo.

Loddick SA, Ross SJ, Thomason AG, Robinson DM, Walker GE, Dunkley TP, Brave SR, Broadbent N, Stratton NC, Trueman D, Mouchet E, Shaheen FS, Jacobs VN, Cumberbatch M, Wilson J, Jones RD, Bradbury RH, Rabow A, Gaughan L, Womack C, Barry ST, Robson CN, Critchlow SE, Wedge SR, Brooks AN.

Mol Cancer Ther. 2013 Sep;12(9):1715-27. doi: 10.1158/1535-7163.MCT-12-1174. Epub 2013 Jul 16.

21.

Discovery of AZD3514, a small-molecule androgen receptor downregulator for treatment of advanced prostate cancer.

Bradbury RH, Acton DG, Broadbent NL, Brooks AN, Carr GR, Hatter G, Hayter BR, Hill KJ, Howe NJ, Jones RD, Jude D, Lamont SG, Loddick SA, McFarland HL, Parveen Z, Rabow AA, Sharma-Singh G, Stratton NC, Thomason AG, Trueman D, Walker GE, Wells SL, Wilson J, Wood JM.

Bioorg Med Chem Lett. 2013 Apr 1;23(7):1945-8. doi: 10.1016/j.bmcl.2013.02.056. Epub 2013 Feb 21.

PMID:
23466225
22.

Vilazodone for the treatment of major depressive disorder.

Iranikhah M, Wensel TM, Thomason AR.

Pharmacotherapy. 2012 Oct;32(10):958-65. doi: 10.1002/j.1875-9114.2012.01121.

PMID:
23033234
23.

Names do matter.

Thomason A.

Aust Fam Physician. 2009 Sep;38(9):663. No abstract available.

PMID:
19911434
24.

Pharmacists' advancing roles in drug and disease management: a review of states' legislation.

McKnight AG, Thomason AR.

J Am Pharm Assoc (2003). 2009 Jul-Aug;49(4):554-8. doi: 10.1331/JAPhA.2009.08056. Review.

PMID:
19589769
25.

Structural and mechanistic exploration of acid resistance: kinetic stability facilitates evolution of extremophilic behavior.

Kelch BA, Eagen KP, Erciyas FP, Humphris EL, Thomason AR, Mitsuiki S, Agard DA.

J Mol Biol. 2007 May 4;368(3):870-83. Epub 2007 Feb 22.

PMID:
17382344
26.

Urinary incontinence symptoms during and after pregnancy in continent and incontinent primiparas.

Thomason AD, Miller JM, Delancey JO.

Int Urogynecol J Pelvic Floor Dysfunct. 2007 Feb;18(2):147-51. Epub 2006 Apr 20.

PMID:
16625310
27.

Childbirth and pelvic floor dysfunction: an epidemiologic approach to the assessment of prevention opportunities at delivery.

Patel DA, Xu X, Thomason AD, Ransom SB, Ivy JS, DeLancey JO.

Am J Obstet Gynecol. 2006 Jul;195(1):23-8. Epub 2006 Mar 30.

28.

Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality.

Farrell CL, Bready JV, Rex KL, Chen JN, DiPalma CR, Whitcomb KL, Yin S, Hill DC, Wiemann B, Starnes CO, Havill AM, Lu ZN, Aukerman SL, Pierce GF, Thomason A, Potten CS, Ulich TR, Lacey DL.

Cancer Res. 1998 Mar 1;58(5):933-9.

29.
30.

Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2.

Zhang K, Sun J, Liu N, Wen D, Chang D, Thomason A, Yoshinaga SK.

J Biol Chem. 1996 Feb 16;271(7):3884-90.

31.

Pulmonary malformation in transgenic mice expressing human keratinocyte growth factor in the lung.

Simonet WS, DeRose ML, Bucay N, Nguyen HQ, Wert SE, Zhou L, Ulich TR, Thomason A, Danilenko DM, Whitsett JA.

Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12461-5.

32.
33.

A novel intracellular epithelial cell tyrosine kinase is expressed in the skin and gastrointestinal tract.

Vasioukhin V, Serfas MS, Siyanova EY, Polonskaia M, Costigan VJ, Liu B, Thomason A, Tyner AL.

Oncogene. 1995 Jan 19;10(2):349-57.

PMID:
7838533
34.

A case of fractured femoral neck at two levels.

Thomason AJ, Marya SK, Samuel AW.

Injury. 1994 May;25(4):273-4. No abstract available.

PMID:
8206666
35.

Formation of mitogenically active PDGF-B dimer does not require interchain disulfide bonds.

Kenney WC, Haniu M, Herman AC, Arakawa T, Costigan VJ, Lary J, Yphantis DA, Thomason AR.

J Biol Chem. 1994 Apr 22;269(16):12351-9.

36.
37.

Fungal osteomyelitis of the foot. A report of an unusual case.

Shaw CJ, Thomason AJ, Spencer JD.

J Bone Joint Surg Br. 1994 Jan;76(1):137-9.

PMID:
8300658
38.

Recombinant human platelet-derived growth factor-BB for the treatment of chronic pressure ulcers.

Robson MC, Phillips LG, Thomason A, Altrock BW, Pence PC, Heggers JP, Johnston AF, McHugh TP, Anthony MS, Robson LE, et al.

Ann Plast Surg. 1992 Sep;29(3):193-201.

PMID:
1524367
40.

Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity.

Usuki K, Saras J, Waltenberger J, Miyazono K, Pierce G, Thomason A, Heldin CH.

Biochem Biophys Res Commun. 1992 May 15;184(3):1311-6.

PMID:
1590793
41.

Platelet-derived growth factor BB for the treatment of chronic pressure ulcers.

Robson MC, Phillips LG, Thomason A, Robson LE, Pierce GF.

Lancet. 1992 Jan 4;339(8784):23-5.

PMID:
1345953
42.

Role of alpha beta receptor heterodimer formation in beta platelet-derived growth factor (PDGF) receptor activation by PDGF-AB.

Heidaran MA, Pierce JH, Yu JC, Lombardi D, Artrip JE, Fleming TP, Thomason A, Aaronson SA.

J Biol Chem. 1991 Oct 25;266(30):20232-7.

43.

Elevated plasma platelet-derived growth factor B-chain levels in cancer patients.

Leitzel K, Bryce W, Tomita J, Manderino G, Tribby I, Thomason A, Billingsley M, Podczaski E, Harvey H, Bartholomew M, et al.

Cancer Res. 1991 Aug 15;51(16):4149-54.

44.

Stable methylation patterns of MYC and other genes regulated during terminal myeloid differentiation.

Lübbert M, Salser W, Prokocimer M, Miller CW, Thomason A, Koeffler HP.

Leukemia. 1991 Jul;5(7):533-9.

PMID:
1649355
45.

Role of platelet-derived growth factor in wound healing.

Pierce GF, Mustoe TA, Altrock BW, Deuel TF, Thomason A.

J Cell Biochem. 1991 Apr;45(4):319-26. Review.

PMID:
2045423
46.
47.

Reversal of impaired wound healing in irradiated rats by platelet-derived growth factor-BB.

Mustoe TA, Purdy J, Gramates P, Deuel TF, Thomason A, Pierce GF.

Am J Surg. 1989 Oct;158(4):345-50.

PMID:
2508504
48.

In vivo incisional wound healing augmented by platelet-derived growth factor and recombinant c-sis gene homodimeric proteins.

Pierce GF, Mustoe TA, Senior RM, Reed J, Griffin GL, Thomason A, Deuel TF.

J Exp Med. 1988 Mar 1;167(3):974-87.

49.

Identification and purification of PDGF/sis-like proteins from nuclei of simian sarcoma virus-transformed fibroblasts.

Pierce GF, Shawver LK, Milner PG, Yeh HJ, Thomason A, Deuel TF.

Oncogene Res. 1988 Feb;2(3):235-44.

PMID:
2835737
50.

Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta.

Mustoe TA, Pierce GF, Thomason A, Gramates P, Sporn MB, Deuel TF.

Science. 1987 Sep 11;237(4820):1333-6.

PMID:
2442813

Supplemental Content

Loading ...
Support Center